Home > Publications > Influenza Bibliography
 

March 2002 :: Vol 32 No 3

Clinical and prevention

  1. Bertz, H., Illerhaus, G., Veelken, H., and Finke, J. (2002) Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens. Annals of Oncology. vol. 13(1) 135-139
  2. Beyer, W. E. P., Palache, A. M., De Jong, J. C., and Osterhaus Adme (2002) Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy A meta-analysis. Vaccine. vol. 20(9-10) 1340-1353
  3. Castelnovo, G., Sotto, A., Bouly, S., Vladut, M., Janbon, F., and Labauge, P. (2002) Meningo encephalitis revealing Q fever: two cases and a review of the literature. Revue Neurologique. vol. 158(1) 77-80
  4. Cheer, S. M. and Wagstaff, A. J. (2002) Zanamivir - An update of its use in influenza. Drugs. vol. 62(1) 71-106
  5. Church, D. L., Davies, H. D., Mitton, C., Semeniuk, H., Logue, M., Maxwell, C., and Donaldson, C. (2002) Clinical and economic evaluation of rapid influenza A virus testing in nursing homes in Calgary, Canada. Clinical Infectious Diseases. vol. 34(6) 790-795
  6. Couch, R. B. (2002) Influenza: Prospects for control - Response. Annals of Internal Medicine. vol. 136(4) 338-339
  7. Destefano, F. and Kramarz, P. (2002) Influenza vaccine and asthma - Reply. Journal of Pediatrics. vol. 140(2) p. 279
  8. Gonzalez-Cid, M., Fundia, A. F., Cuello, M. T., and Larripa, I. (2002) Correlation between chromosome damage and apoptosis induced by fludarabine and idarubicin in normal human lymphocytes. Toxicology. vol. 171(2-3) 215-222
  9. Greenbaum, E., Furst, A., Kiderman, A., Stewart, B., Levy, R., Schlesinger, M., Morag, A., and Zakay-Rones, Z. (2002) Mucosal [SIgA] and serum [IgG] immunologic responses in the community after a single intra-nasal immunization with a new inactivated trivalent influenza vaccine. Vaccine. vol. 20(7-8) 1232-1239
  10. Halperin, S. A., Smith, B., Mabrouk, T., Germain, M., Trepanier, P., Hassell, T., Treanor, J., Gauthier, R., and Mills, E. L. (2002) Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children. Vaccine. vol. 20(7-8) 1240-1247
  11. Hernandez, M., Borrull, F., and Calull, M. (2002) Using nonaqueous capillary electrophoresis to analyze several quinolones in pig kidney samples. Electrophoresis. vol. 23(3) 506-511
  12. Johnston, S. L. (2002) Anti-influenza therapies. Virus Research. vol. 82(1-2) 147-152
  13. Josefson, D. (2002) US encourages flu jabs for infants aged under 2. British Medical Journal. vol. 324(7336) p. 502
  14. Kravtzoff, R., Major, M., De Miguel, I., Le Ber, C., Etienne, A., and Betbeder, D. (2002) Light Biovector: a nanoparticle delivery system developed for the nasal administration of vaccines. Stp Pharma Sciences. vol. 12(1) 45-51
  15. Li, D. and Rozen, T. D. (2002) The clinical characteristics of new daily persistent headache. Cephalalgia. vol. 22(1) 66-69
  16. Magann, E. F., Evans, S. F., Weitz, B., and Newnham, J. (2002) Antepartum, intrapartum, and neonatal significance of exercise on healthy low-risk pregnant working women. Obstetrics and Gynecology. vol. 99(3) 466-472
  17. Mazza, J. J. and Yale, S. H. (2002) Influenza: Prospects for control. Annals of Internal Medicine. vol. 136(4) p. 338
  18. Monath, T. P., Mccarthy, K., Bedford, P., Johnson, C. T., Nichols, R., Yoksan, S., Marchesani, R., Knauber, M., Wells, K. H., Arroyo, J., and Guirakhoo, F. (2002) Clinical proof of principle for ChimeriVax (TM): recombinant live, attenuated vaccines against flavivirus infections. Vaccine. vol. 20(7-8) 1004-1018
  19. Robertson, W. C. (2002) Carbamazepine toxicity after influenza vaccination. Pediatric Neurology. vol. 26(1) 61-63
  20. Stephenson, J. (2002) Flu shots for stroke prevention? Jama-Journal of the American Medical Association. vol. 287(10) p. 1255
  21. Treanor, J., Keitel, W., Belshe, R., Campbell, J., Schiff, G., Zangwill, K., Wolff, M., Klimov, A., Levandowski, R., and Lambert, L. (2002) Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults. Vaccine. vol. 20(7-8) 1099-1105
  22. Van Der Wouden, J. C., Bueving, H. J., and Bernsen, R. M. D. (2002) Influenza vaccine and asthma. Journal of Pediatrics. vol. 140(2) 278-279

    23. Epidemiology

  23. Uyeki, T., Postema, A., Brammer, L., Hall, H., Klimov, A., Fukuda, K., Cox, N., Who Collaborating Labs, and Cdc (2002) Update: Influenza activity - United States, 2001-02 season (Reprinted from MMWR, vol 51, pg 78-91, 2002). Jama-Journal of the American Medical Association. vol. 287(9) 1107-1108

    24. Immunology

  24. Beignon, A. S., Briand, J. P., Muller, S., and Partidos, C. D. (2002) Immunization onto bare skin with synthetic peptides: immunomodulation with a CpG-containing oligodeoxynucleotide and effective priming of influenza virus-specific CD4(+) T cells. Immunology. vol. 105(2) 204-212
  25. Boon, A. C. M., Vos, A. P., Graus, Y. M. F., Rimmelzwaan, G. F., and Osterhaus Adme (2002) In vitro effect of bioactive compounds on influenza virus specific B- and T-cell responses. Scandinavian Journal of Immunology. vol. 55(1) 24-32
  26. Cox, R. J., Mykkeltvedt, E., Robertson, J., and Haaheim, L. R. (2002) Non-lethal viral challenge of influenza haemagglutinin and nucleoprotein DNA vaccinated mice results in reduced viral replication. Scandinavian Journal of Immunology. vol. 55(1) 14-23
  27. Kaufmann, A., Salentin, R., Meyer, R. G., Bussfeld, D., Pauligk, C., Fesq, H., Hofmann, P., Nain, M., Gemsa, D., and Sprenger, H. (2001) Defense against influenza A virus infection: Essential role of the chemokine system. Immunobiology. vol. 204(5) 603-613
  28. Levine, A. M., Hartshorn, K., Elliott, J., Whitsett, J., and Korfhagen, T. (2002) Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection. American Journal of Physiology-Lung Cellular and Molecular Physiology. vol. 282(3) p. L563-L572
  29. Lu, X. H., Clements, J. D., and Katz, J. M. (2002) Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine. Vaccine. vol. 20(7-8) 1019-1029
  30. Mazzone, P. J., Mossad, S. B., Mawhorter, S. D., Mehta, A. C., Schilz, R. J., and Maurer, J. R. (2001) The humoral immune response to influenza vaccination in lung transplant patients. European Respiratory Journal. vol. 18(6) 971-976
  31. Subauste, M. C., List, B., Guan, X. J., Hahn, K. M., Lerner, R., and Gilula, N. B. (2001) A catalytic antibody produces fluorescent tracers of gap junction communication in living cells. Journal of Biological Chemistry. vol. 276(52) 49164-49168

    32. Structure, function and genetics

  32. Boros, C., Katz, B., Mitchell, S., Pearce, C., Swinbank, K., and Taylor, D. (2002) Emmyguyacins A and B: Unusual glycolipids from a sterile fungus species that inhibit the low-pH conformational change of hemagglutinin A during replication of influenza virus. Journal of Natural Products. vol. 65(2) 108-114
  33. Hasegawa, H., Kadowaki, S., Watanabe, I., Aizawa, H., Takahashi, H., Iwasaki, T., Tamura, S., Kurata, T., and Sata, T. (2002) Persistent infection of influenza virus in irradiated mice and its prevention by intranasal vaccination. Vaccine. vol. 20(7-8) 1050-1057
  34. Ikizler, M. R. and Wright, P. F. (2002) Thermostabilization of egg grown influenza viruses. Vaccine. vol. 20(9-10) 1393-1399
  35. Klenk, H. D., Wagner, R., Heuer, D., and Wolff, T. (2002) Importance of hemagglutinin glycosylation for the biological functions of influenza virus. Virus Research. vol. 82(1-2) 73-75
  36. Knox, Y. M., Hayashi, K., Suzutani, T., Ogasawara, M., Yoshida, I., Shiina, R., Tsukui, A., Terahara, N., and Azuma, M. (2001) Activity of anthocyanins from fruit extract of Ribes nigrum L. against influenza A and B viruses. Acta Virologica. vol. 45(4) 209-215
  37. Lommer, B. S. and Luo, M. (2002) Structural plasticity in influenza virus protein NS2 (NEP). Journal of Biological Chemistry. vol. 277(9) 7108-7117
  38. Lu, F. J., Tseng, S. N., Li, M. L., and Shih, S. R. (2002) In vitro anti-influenza virus activity of synthetic humate analogues derived from protocatechuic acid. Archives of Virology. vol. 147(2) 273-284
  39. Maksaev, G. I., Mikhaliov, I. I., and Frolov, V. A. (2001) Electrical activity, observed during fusion of single influenza virions with lipid bilayers. Biologicheskie Membrany. vol. 18(6) 489-495
  40. Minagawa, K., Kouzuki, S., and Kamigauchi, T. (2002) Stachyflin and acetylstachyflin, novel anti-influenza A virus substances, produced by Stachybotrys sp RF-7260 II. Synthesis and preliminary structure-activity relationships of stachyflin derivatives. Journal of Antibiotics. vol. 55(2) 165-171
  41. Minagawa, K., Kouzuki, S., Yoshimoto, J., Kawamura, Y., Tani, H., Iwata, T., Terui, Y., Nakai, H., Yagi, S., Hattori, N., Fujiwara, T., and Kamigauchi, T. (2002) Stachyflin and acetylstachyflin, novel anti-influenza A virus substances, produced by Stachybotrys sp RF-7260 I. Isolation, structure elucidation and biological activities. Journal of Antibiotics. vol. 55(2) 155-164
  42. Nedyalkova, M. S., Hayden, F. G., Webster, R. G., and Gubareva, L. V. (2002) Accumulation of defective neuraminidase (NA) genes by influenza A viruses in the presence of NA inhibitors as a marker of reduced dependence on NA. Journal of Infectious Diseases. vol. 185(5) 591-598
  43. Neumann, G. and Kawaoka, Y. (2002) Synthesis of influenza virus: new impetus from an old enzyme, RNA polymerase I. Virus Research. vol. 82(1-2) 153-158
  44. Ohtsu, Y., Honda, Y., Sakata, Y., Kato, H., and Toyoda, T. (2002) Fine mapping of the subunit binding sites of influenza virus RNA polymerase. Microbiology and Immunology. vol. 46(3) 167-175
  45. Prokundina, E. N., Semenova, N. P., Rudneva, I. A., Chumakov, V. M., and Yamnikova, S. S. (2001) Avian and human influenza A virus strains possess different intracellular nucleoprotein oligomerization efficiency. Acta Virologica. vol. 45(4) 201-207
  46. Sunazuka, T., Shirahata, T., Yoshida, K., Yamamoto, D., Harigaya, Y., Nagai, T., Kiyohara, H., Yamada, H., Kuwajima, I., and Omura, S. (2002) Total synthesis of pinellic acid, a potent oral adjuvant for nasal influenza vaccine. Determination of the relative and absolute configuration. Tetrahedron Letters. vol. 43(7) 1265-1268
  47. Wagner, R., Heuer, D., Wolff, T., Herwig, A., and Klenk, H. D. (2002) N-glycans attached to the stem domain of haemagglutinin efficiently regulate influenza A virus replication. Journal of General Virology. vol. 83 601-609